Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 51
Filter
1.
Histol Histopathol ; 24(1): 101-6, 2009 01.
Article in English | MEDLINE | ID: mdl-19012249

ABSTRACT

Many human solid cancers arise from focal proliferative lesions that long precede the overt clinical appearance of the disease. The available evidence supports the notion that cancer precursor lesions are clonal in origin, and this notion forms the basis for most of the current theories on the pathogenesis of neoplastic disease. In contrast, far less attention has been devoted to the analysis of the phenotypic property that serves to define these focal lesions, i.e. their altered growth pattern. In fact, the latter is often considered a mere morphological by-product of clonal growth, with no specific relevance in the process. In the following study, evidence will be presented to support the concept that focal growth pattern is an inherent property of altered cells, independent of clonal growth; furthermore, it will be discussed how such a property, far from being merely descriptive, might indeed play a fundamental role in the sequence of events leading to the development of cancer. Within this paradigm, the earliest steps of neoplasia should be considered and analysed as defects in the mechanisms of tissue pattern formation.


Subject(s)
Cell Proliferation , Cell Transformation, Neoplastic/pathology , Neoplasms/pathology , Animals , Body Patterning/physiology , Humans
2.
Diagn Mol Pathol ; 10(3): 200-6, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11552723

ABSTRACT

This study describes a nonisotopic polymerase chain reaction-reverse hybridization-based method (PCR-RH) for the one-step detection and genotyping of anogenital human papillomavirus (HPV) in a microwell format. HPV DNA was amplified and labeled by PCR using GP5+/GP6+ primers. Labeled amplicons were hybridized to 20 HPV type-specific capture probes anchored to the surface of plastic microwells and detected by an immunoenzymatic assay. Assay sensitivity was <50 pg labeled amplicon, and no cross-reactivity was observed, as determined by hybridizing serial dilutions of labeled PCR products to either matched or mismatched capture probes. The assay was tested on 66 clinical samples (23 specimens with normal histology, I fibropapilloma, 26 cervical intraepithelial neoplasia grade 1 [CIN1], 9 CIN2, and 7 CIN3) and compared with a method based on restriction fragment length polymorphism (RFLP) of PCR products. PCR-RH and PCR-RFLP performed equally well on clinical samples. The overall HPV detection rate was similar: 65.1% (43/66) for PCR-RH and 57.6% (38/66) for PCR-RFLP. HPV DNA was found in all CIN2 and CIN3 samples by both methods; however, PCR-RH detected more positives among normal biopsy samples and CINI cases. Overall, there was good agreement between the two genotyping methods, but RH yielded fewer cases with undetermined HPV genotype.


Subject(s)
DNA, Viral/analysis , Nucleic Acid Hybridization/methods , Papillomaviridae/genetics , Papillomaviridae/isolation & purification , Polymerase Chain Reaction/methods , Uterine Cervical Dysplasia/virology , Uterine Cervical Neoplasms/virology , Consensus Sequence , DNA Primers/chemistry , Female , Genotype , Humans , Papillomaviridae/classification , Polymorphism, Restriction Fragment Length , Sensitivity and Specificity , Uterine Cervical Neoplasms/pathology , Uterine Cervical Dysplasia/pathology
3.
Proc Natl Acad Sci U S A ; 98(14): 7806-11, 2001 Jul 03.
Article in English | MEDLINE | ID: mdl-11427708

ABSTRACT

We recently have shown that selective growth of transplanted normal hepatocytes can be achieved in a setting of cell cycle block of endogenous parenchymal cells. Thus, massive proliferation of donor-derived normal hepatocytes was observed in the liver of rats previously given retrorsine (RS), a naturally occurring alkaloid that blocks proliferation of resident liver cells. In the present study, the fate of nodular hepatocytes transplanted into RS-treated or normal syngeneic recipients was followed. The dipeptidyl peptidase type IV-deficient (DPPIV(-)) rat model for hepatocyte transplantation was used to distinguish donor-derived cells from recipient cells. Hepatocyte nodules were chemically induced in Fischer 344, DPPIV(+) rats; livers were then perfused and larger (>5 mm) nodules were separated from surrounding tissue. Cells isolated from either tissue were then injected into normal or RS-treated DPPIV(-) recipients. One month after transplantation, grossly visible nodules (2--3 mm) were seen in RS-treated recipients transplanted with nodular cells. They grew rapidly, occupying 80--90% of the host liver at 2 months, and progressed to hepatocellular carcinoma within 4 months. By contrast, no liver nodules developed within 6 months when nodular hepatocytes were injected into the liver of recipients not exposed to RS, although small clusters of donor-derived cells were present in these animals. Taken together, these results directly point to a fundamental role played by the host environment in modulating the growth and the progression rate of altered cells during carcinogenesis. In particular, they indicate that conditions associated with growth constraint of the host tissue can drive tumor progression in vivo.


Subject(s)
Carcinoma, Hepatocellular/pathology , Cell Transformation, Neoplastic , Liver Neoplasms, Experimental/pathology , Liver/pathology , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Carcinoma, Hepatocellular/etiology , Carcinoma, Hepatocellular/genetics , Cell Division , Cell Transplantation , Dipeptidyl Peptidase 4/genetics , Liver Neoplasms, Experimental/etiology , Liver Neoplasms, Experimental/genetics , Male , Pyrrolizidine Alkaloids/pharmacology , Rats , Rats, Inbred F344
4.
Am J Pathol ; 158(2): 771-7, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11159214

ABSTRACT

A strategy for hepatocyte transplantation was recently developed whereby massive replacement of the recipient liver is achieved after a combined treatment with retrorsine, a pyrrolizidine alkaloid, and partial hepatectomy. We now investigated whether liver repopulation could occur in this animal model in the absence of any exogenous growth stimuli (eg, partial hepatectomy) for the transplanted cells. Dipeptidyl-peptidase type IV-deficient (DPPIV-) rats were used as recipients. Rats were given two injections of retrorsine (30 mg/kg each, 2 weeks apart), followed by transplantation of 2 x 10(6) hepatocytes isolated from a normal, syngeneic, DPPIV+ donor. At 2 weeks after transplantation, clusters of DPPIV+ hepatocytes occupied 3.3 +/- 0.9% of host liver, increasing to 38.2 +/- 6.3% at 2 months, and to 65.9 +/- 8.8% at 5 months. By 1 year, >95% of the original hepatocytes were replaced by donor-derived cells. Serum parameters related both to hepatocyte function and integrity (including glucose, bilirubin, total proteins, cholinesterase, alanine aminotransferase, and alkaline phosphatase) were in the normal range in retrorsine-treated and repopulated animals. These results provide further insights toward developing strategies for effective liver repopulation by transplanted hepatocytes with reduced toxicity for the host and potential clinical applicability.


Subject(s)
Cell Transplantation , Hepatocytes/cytology , Liver Transplantation/methods , Pyrrolizidine Alkaloids/pharmacology , Animals , Bilirubin/blood , Blood Glucose/drug effects , Blood Glucose/metabolism , Cell Division/drug effects , DNA/drug effects , DNA/metabolism , Dipeptidyl Peptidase 4/genetics , Dipeptidyl Peptidase 4/metabolism , Female , Glutathione Transferase/metabolism , Hepatectomy , Hepatocytes/enzymology , Isoenzymes/metabolism , Liver/cytology , Liver/drug effects , Liver/surgery , Male , Rats , Rats, Inbred F344 , Rats, Mutant Strains , Sex Factors , Time Factors
5.
Cancer Lett ; 161(2): 215-20, 2000 Dec 20.
Article in English | MEDLINE | ID: mdl-11090972

ABSTRACT

This study examines the effect of a stress-associated condition on chemical hepatocarcinogenesis in the rat. Rats were given diethylnitrosamine (200 mg/kg. b.w., i.p.), followed, 1 week later, by three cycles of immobilization at room temperature. Two weeks after the last cycle they were treated according to the resistant hepatocyte protocol. At 4 weeks after selection, mean size of glutathione-S-transferase 7-7 positive foci/nodules was increased in the immobilized group (0.82+/-0.22 vs. 0.25+/-0.04 mm(2) in controls). Furthermore, at the end of 1 year 10/13 animals (77%) developed hepatocellular carcinoma in the former group, while only 6/14 (43%) incidence of cancer was found in controls. These results indicate that exposure to restraint stress early during carcinogenesis enhances the development of chemically-induced hepatocellular carcinoma in the rat.


Subject(s)
Liver Neoplasms/chemically induced , Stress, Physiological , Animals , Body Weight , Carcinogens , Carcinoma, Hepatocellular/chemically induced , Carcinoma, Hepatocellular/prevention & control , Diethylnitrosamine , Glutathione Transferase/metabolism , Immobilization , Male , Organ Size , Rats , Rats, Inbred F344 , Temperature , Time Factors
6.
Pathologica ; 92(4): 236-40, 2000 Aug.
Article in Italian | MEDLINE | ID: mdl-11029883

ABSTRACT

INTRODUCTION: Human Papillomavirus (HPV) infection is considered an important risk factor for the development of cervical carcinoma. The aim of this work was to detect and genotype HPV DNA in cervical lesions from our Province. METHODS: HPV DNA was amplified by polymerase chain reaction (PCR) and genotyped by restriction fragment length polymorphism (RFLP) analysis. A total of 101 biopsies (43 koilocytic atypias, 20 CIN1, 19 CIN2, 17 CIN3 and 2 squamous carcinomas) were analyzed. RESULTS: HPV DNA was found in 41.8% of koilocytic atypias, in 95.0% of CIN1 and 100% of CIN2 and higher grade lesions. Only high risk genotypes were found in CIN2-3 and invasive carcinomas. HPV 16 was the most prevalent type in both CIN1 and CIN2-3 and the only HPV type found in situ and invasive carcinomas. HPV type 51 was found in 21.0% of CIN1 but it was rare in CIN2 and absent in more advanced lesions.


Subject(s)
Carcinoma, Squamous Cell/virology , Cervix Uteri/virology , Papillomaviridae/isolation & purification , Papillomavirus Infections/virology , Tumor Virus Infections/virology , Uterine Cervical Dysplasia/virology , Uterine Cervical Neoplasms/virology , Adult , Aged , Biopsy , Carcinoma, Squamous Cell/pathology , Cervix Uteri/pathology , DNA Probes, HPV , DNA, Viral/analysis , Female , Genotype , Humans , Italy/epidemiology , Middle Aged , Papillomaviridae/classification , Papillomaviridae/genetics , Papillomavirus Infections/epidemiology , Papillomavirus Infections/pathology , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Tumor Virus Infections/epidemiology , Tumor Virus Infections/pathology , Uterine Cervical Dysplasia/pathology , Uterine Cervical Neoplasms/pathology
7.
Am J Pathol ; 156(6): 2017-31, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10854224

ABSTRACT

To identify cells that have the ability to proliferate and differentiate into all epithelial components of the liver lobule, we isolated fetal liver epithelial cells (FLEC) from ED 14 Fischer (F) 344 rats and transplanted these cells in conjunction with two-thirds partial hepatectomy into the liver of normal and retrorsine (Rs) treated syngeneic dipeptidyl peptidase IV mutant (DPPIV(-)) F344 rats. Using dual label immunohistochemistry/in situ hybridization, three subpopulations of FLEC were identified: cells expressing both alpha-fetoprotein (AFP) and albumin, but not CK-19; cells expressing CK-19, but not AFP or albumin, and cells expressing AFP, albumin, and cytokeratins-19 (CK-19). Proliferation, differentiation, and expansion of transplanted FLEC differed significantly in the two models. In normal liver, 1 to 2 weeks after transplantation, mainly cells with a single phenotype, hepatocytic (expressing AFP and albumin) or bile ductular (expressing only CK-19), had proliferated. In Rs-treated rats, in which the proliferative capacity of endogenous hepatocytes is impaired, transplanted cells showed mainly a dual phenotype (expressing both AFP/albumin and CK-19). One month after transplantation, DPPIV(+) FLEC engrafted into the parenchyma exhibited an hepatocytic phenotype and generated new hepatic cord structures. FLEC, localized in the vicinity of bile ducts, exhibited a biliary epithelial phenotype and formed new bile duct structures or were incorporated into pre-existing bile ducts. In the absence of a proliferative stimulus, ED 14 FLEC did not proliferate or differentiate. Our results demonstrate that 14-day fetal liver contains lineage committed (unipotential) and uncommitted (bipotential) progenitor cells exerting different repopulating capacities, which are affected by the proliferative status of the recipient liver and the host site within the liver where the transplanted cells become engrafted. These findings have important implications in future studies directed toward liver repopulation and ex vivo gene therapy.


Subject(s)
Cell Transplantation , Fetal Tissue Transplantation , Liver/cytology , Liver/surgery , Stem Cells/cytology , Animals , Bile Ducts/cytology , Cell Differentiation/drug effects , Cell Division/drug effects , Cell Line , Epithelial Cells/cytology , Hepatectomy/methods , Liver/embryology , Mitogens/pharmacology , Postoperative Period , Pyrrolizidine Alkaloids/pharmacology , Rats , Rats, Inbred F344 , Transplantation, Isogeneic , Triiodothyronine/pharmacology
9.
Pathologica ; 92(6): 524-9, 2000 Dec.
Article in Italian | MEDLINE | ID: mdl-11234303

ABSTRACT

INTRODUCTION: Genotyping of Human papillomavirus (HPV) is an important step in the clinical evaluation of the oncogenic risk associated with HPV infection of cervical mucosa. The purpose of this work was to develop a fast PCR-reverse-hybridization assay (PCR-RH) for the simultaneous detection and genotyping of anogenital HPVs. METHODS: HPV DNA from cervical biopsies was amplified by consensus primer-PCR. Digoxigenin-labeled PCR products were hybridized to type-specific probes anchored to the surface of plastic microwells and revealed by an ELISA system. RESULTS: The method was tested on 115 clinical samples (81 koilocytic atypias, 11 CIN1, 10 CIN2, 12 CIN3 and 1 squamous carcinoma). HPV DNA was found in 56.7% koilocytic atypias, in 90.9% of CIN1 and in 100% of CIN2 and higher-grade lesions. Thus, PCR-RH is sensitive, rapid, easy-to-perform and readily applicable to the routine analysis of a large number of samples.


Subject(s)
Cervix Uteri/virology , DNA Probes, HPV , DNA, Viral/analysis , Enzyme-Linked Immunosorbent Assay , Nucleic Acid Hybridization/methods , Papillomavirus Infections/virology , Polymerase Chain Reaction , Tumor Virus Infections/virology , Uterine Cervicitis/virology , Biopsy , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/virology , Cervix Uteri/pathology , Digoxigenin , Female , Humans , Papillomavirus Infections/diagnosis , Papillomavirus Infections/pathology , Polymorphism, Restriction Fragment Length , Tumor Virus Infections/diagnosis , Tumor Virus Infections/pathology , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology , Uterine Cervicitis/diagnosis , Uterine Cervicitis/pathology , Uterine Cervical Dysplasia/pathology , Uterine Cervical Dysplasia/virology
10.
Lancet Oncol ; 1: 235-41, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11905641

ABSTRACT

Phenotypic resistance, acquired early in carcinogenesis, has an established role in the pathogenesis of cancer in well-characterised experimental systems, and possibly also has a role in the origin of human cancer. It has been suggested that sunlight, an established risk factor for human skin carcinogenesis, is able to induce rare altered cells resistant to toxicity and to favour their clonal expansion via toxic effects exerted on normal keratinocytes. Other major risk factors for human neoplasia, including smoking and ageing, may also act partly through imposition of a constrained growth environment in the target organ to favour the emergence of altered resistant cells. Strategies aimed at counteracting this constrained environment could be effective in attenuating the force that sustains clonal expansion of altered cells.


Subject(s)
Antineoplastic Agents/administration & dosage , Drug Resistance/genetics , Neoplasms/drug therapy , Neoplasms/genetics , Phenotype , Animals , Antineoplastic Agents/adverse effects , Clinical Trials as Topic , Disease Models, Animal , Drug Resistance/physiology , Humans , Neoplasms/pathology , Rats , Risk Assessment , Risk Factors , Sensitivity and Specificity , Treatment Failure
11.
J Hepatol ; 31(6): 1069-74, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10604581

ABSTRACT

BACKGROUND/AIM: We have designed an experimental model in which transplantation of normal hepatocytes into rats previously treated with retrorsine (a naturally-occurring pyrrolizidine alkaloid) results in near-complete replacement of the recipient liver by donor-derived cells. Two/thirds partial hepatectomy was found to be essential for this process to occur. To probe this finding, in the present study we describe the kinetics of liver regeneration in response to partial hepatectomy in rats given retrorsine. METHODS: Six-weeks-old male Fisher 344 rats received retrorsine (2 injections of 30 mg/kg each, i.p., 2 weeks apart), or the vehicle. Four weeks after the last injection, partial hepatectomy was performed and rats were killed at 1, 2, 3, 6, and 15 days thereafter. RESULTS: At time zero, i.e. prior to partial hepatectomy, liver weight and total liver DNA content were significantly lower in retrorsine-treated animals compared to controls (DNA content: 19.2+/-1.7 vs. 25.7+/-1.1 mg/liver). Diffuse megalocytosis (enlarged hepatocytes) was present in the group exposed to retrorsine. By day 3 post-partial hepatectomy liver DNA content in control animals had more than doubled compared to day 1 values (20.2+/-1.5 vs. 8.8+/-1.2), while very little increase was seen in retrorsine-treated rats at the same time points (7.6+/-0.4 vs. 6.1+/-0.2). At 2 weeks after partial hepatectomy, total DNA content returned close to normal levels in the control group (26.9+/-1.0 mg/liver); however, the value was still very low in animals receiving retrorsine (9.1+/-0.7). Data on BrdU labeling were consistent with this pattern and indicated that DNA synthesis following partial hepatectomy was largely inhibited in the retrorsine group. Similarly, no mitotic response was observed in hepatocytes following partial hepatectomy in animals exposed to retrorsine. CONCLUSIONS: These results clearly indicate that retrorsine exerts a strong and persistent cell cycle block on hepatocyte proliferation. Further, these results are in agreement with the hypothesis that selective proliferation of transplanted hepatocytes in retrorsine-treated animals is dependent, at least in part, on the persistent cell cycle block imposed by the alkaloid on endogenous parenchymal cells.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Liver Regeneration/drug effects , Pyrrolizidine Alkaloids/pharmacology , Animals , Cell Cycle/drug effects , Hepatectomy , Male , Rats , Rats, Inbred F344
12.
Carcinogenesis ; 20(10): 1979-83, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10506114

ABSTRACT

Caloric restriction has been associated with a delay in the development of both spontaneous and induced neoplasia. In contrast, cycles of fasting/refeeding were shown by us and others to enhance the incidence of early lesions during chemical carcinogenesis in rat liver. The present, long-term study was undertaken to establish whether such a diffential effect would also extend to the later phases of cancer development, until the overt appearance of neoplasia. Male Fischer 344 rats were initiated with a single dose of diethylnitrosamine (DENA, 200 mg/kg i.p.) and starting 1 week later they were either exposed to three cycles of fasting (3 days) followed by refeeding (11 days) or were fed continuously. Seven weeks after DENA administration the rats were exposed to the resistant hepatocyte model of the liver tumor promotion protocol. All animals were killed 1 year after initiation. Incidence of hepatocellular carcinoma was 2-fold higher in the fasted/refed group compared with the controls (72 versus 36%). In addition, cancers were also larger and of higher histological grade in the former group, with one animal showing metastases to the lungs, while no metastases developed in control animals. Fasting caused a decrease in total liver DNA (from 25.2 +/- 1.1 to 16.5 +/- 1.1 mg after 3 days) which was associated with a decrease in hepatocyte labeling index and mitotic activity and high levels of single cell death (apoptosis). In contrast, a sharp increase in hepatocyte proliferation was observed on day 2 of refeeding and this was more pronounced in glutathione S-transferase 7-7 positive foci compared with surrounding liver (10.2 +/- 2.3 versus 4.6 +/- 0.8%). Such a proliferative wave was associated with a sharp decline in the incidence of cell death. It is concluded that fasting/refeeding performed early after initiation accelerates the development of chemically induced hepatocellular carcinoma in the rat.


Subject(s)
Food , Liver Neoplasms, Experimental/chemically induced , Starvation , Animals , Carcinogens , Diethylnitrosamine , Incidence , Liver Neoplasms, Experimental/epidemiology , Liver Neoplasms, Experimental/pathology , Lung Neoplasms/secondary , Male , Rats , Rats, Inbred F344
13.
Hepatology ; 30(4): 903-13, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10498641

ABSTRACT

Recently, we reported near-complete repopulation of the rat liver by transplanted hepatocytes using retrorsine (RS), a pyrrolizidine alkaloid that alkylates cellular DNA and blocks proliferation of resident hepatocytes, followed by transplantation of normal hepatocytes in conjunction with two-thirds partial hepatectomy (PH). Because two-thirds PH is not feasible for use in humans, in the present study, we evaluated the ability of thyroid hormone (triiodothyronine [T(3)]), a known hepatic mitogen, to stimulate liver repopulation in the retrorsine model. Because T(3) initiates morphogenesis in amphibians through a process involving both cell proliferation and apoptosis, we also determined whether apoptosis might play a role in the mechanism of hepatocyte proliferation induced by T(3). Following hepatocyte transplantation and repeated injections of T(3), the number of transplanted hepatocytes in the liver of RS-pretreated animals increased progressively to repopulate 60% to 80% of parenchymal cell mass in 60 days. We show further that T(3) treatment augments proliferation of normal hepatocytes, as evidenced by increased histone 3 mRNA and cyclin-dependent kinase 2 (cdk2) expression, and this is followed by apoptosis. These combined effects of T(3) lead to selective proliferation of transplanted hepatocytes in RS-pretreated rats, while endogenous hepatocytes, which are blocked in their proliferative capacity by RS, mainly undergo apoptosis. Thus, T(3) can replace PH in the RS-based rat liver repopulation model and therefore represents a significant advance in developing methods for hepatocyte transplantation.


Subject(s)
CDC2-CDC28 Kinases , Cell Transplantation , Liver Regeneration/physiology , Liver/cytology , Triiodothyronine/physiology , Animals , Apoptosis , Cell Division/physiology , Cyclin-Dependent Kinase 2 , Cyclin-Dependent Kinases/metabolism , Histones/genetics , In Situ Hybridization , Liver/drug effects , Liver/metabolism , Liver/physiology , Mitogens/pharmacology , Mitosis , Protein Serine-Threonine Kinases/metabolism , Pyrrolizidine Alkaloids/pharmacology , RNA, Messenger/metabolism , Rats , Rats, Inbred F344 , Triiodothyronine/pharmacology
14.
J Hepatol ; 31(2): 354-9, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10453951

ABSTRACT

BACKGROUND/AIMS: We have recently developed a new model of extensive liver repopulation by transplanted hepatocytes following exposure to pyrrolizidine alkaloids. In the present study, the effect of 2/3 partial hepatectomy (PH) and that of a potent direct liver mitogen, lead nitrate, were compared in their ability to modulate the kinetics of liver repopulation. METHODS: Fischer 344 rats deficient in enzymatic activity for dipeptidyl-peptidase IV (DPPIV-) were used as cell transplantation recipients. They were given 2 doses of the pyrrolizidine alkaloid retrorsine (30 mg/kg, i.p.), 2 weeks apart, followed 2 weeks later by transplantation of 2 x 10(6) hepatocytes (via the portal vein), freshly isolated from a normal congeneic DPPIV+ donor. PH was carried out or a single injection of lead nitrate (100 micromol/kg, i.v.) was administered 2 weeks post-transplantation. Liver samples obtained at different time points post-treatment were processed histochemically for DPPIV activity. RESULTS: The percent of liver sections occupied by DPPIV+ hepatocytes was <1% at the time of PH or lead nitrate administration. In animals which underwent PH, it increased to 33.4+/-5.7% at 2 weeks and to 55.6+/-8.5% at 1 month. However, in animals receiving lead nitrate, these percentages were only 3.3+/-1.3% at 2 weeks and 16.2+/-3.9% at 1 month. Repeated injections of lead nitrate had no additional effect. Further experiments indicated that an acute mitogenic response to lead nitrate was present in transplanted cells, while resident hepatocytes were inhibited by retrorsine. CONCLUSIONS: These results indicate that direct mitogenic signals (such as those induced by lead nitrate), and compensatory signals (such as those elicited by PH), are not equally effective on kinetics of liver repopulation in this system. The possible reasons for these differential effects are discussed.


Subject(s)
Hepatectomy , Lead/pharmacology , Liver Regeneration/drug effects , Liver Regeneration/physiology , Liver/drug effects , Liver/physiopathology , Mitogens/pharmacology , Nitrates/pharmacology , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Cell Transplantation/physiology , Dipeptidyl Peptidase 4/metabolism , Disease Models, Animal , Female , Hyperplasia/chemically induced , Hyperplasia/surgery , Liver/cytology , Liver/enzymology , Liver/pathology , Male , Pyrrolizidine Alkaloids/pharmacology , Rats , Rats, Inbred F344
15.
Semin Liver Dis ; 19(1): 7-14, 1999.
Article in English | MEDLINE | ID: mdl-10349679

ABSTRACT

Recently, it has been shown in several animal models that more than 90% of host hepatocytes can be replaced by a small number of transplanted donor cells in a process we term therapeutic liver repopulation. This phenomenon is analogous to repopulation of the hematopoietic system after bone marrow transplantation. Liver repopulation occurs when transplanted cells have a growth advantage in the setting of damage to recipient liver cells. Here we review the current knowledge of this process and discuss the hopeful implications for treatment of liver diseases.


Subject(s)
Cell Transplantation , Liver Diseases/surgery , Liver/cytology , Animals , Humans
16.
Carcinogenesis ; 20(6): 1143-5, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10357802

ABSTRACT

Our previous studies indicated that glutathione S-transferase 7-7 (GST 7-7) positive foci induced after initiation have a lower threshold towards proliferative stimuli compared with surrounding hepatocytes. This observation would predict that persistent growth stimuli of low intensity could be very effective in promoting the emergence of focal lesions. To test this possibility, the present study was designed to determine the effect of 1/3 partial hepatectomy (PH) on the incidence and growth of foci in initiated rat liver. The rationale for using a 1/3 PH was that it is known to induce a proliferative response which is less intense but more prolonged compared with that elicited by 2/3 PH. Male Fischer 344 rats (110-120 g) were initiated with diethylnitrosamine (200 mg/kg, i.p.). Three weeks later 1/3 PH (median lobe), 2/3 PH (median and left lobes) or sham operation (SH) was performed. An additional group of initiated animals had the median lobe and the left lobe of the liver removed sequentially (1/3 + 1/3 PH), 3 weeks apart. All rats were killed 8 weeks after carcinogen administration. The results indicated that the number of GST 7-7 positive foci was similar in all groups; however, the percent area occupied by foci was increased in rats receiving 2/3 PH compared with SH (0.21 +/- 0. 08 versus 0.09 +/- 0.03). Interestingly, 1/3 PH was nearly as effective as 2/3 PH in stimulating the growth of foci (percent area 0.18 +/- 0.06 versus 0.21 +/- 0.08), although the magnitude of the stimulus is only half for the former group compared with the latter; peak labeling index was 19 +/- 6 with 1/3 PH compared with 40 +/- 2 with 2/3 PH. Moreover, the maximum increase in the size of foci (percent area 0.37 +/- 0.12) was achieved when the median and left lobes were removed sequentially, three weeks apart. These results indicate that persistent growth stimuli of low intensity can be very effective in promoting the growth of focal lesions.


Subject(s)
Glutathione Transferase/metabolism , Liver/physiology , Animals , Carcinogens/pharmacology , DNA/metabolism , Diethylnitrosamine/pharmacology , Hepatectomy , Liver/drug effects , Liver/enzymology , Liver Regeneration , Male , Rats , Rats, Inbred F344
17.
Hepatology ; 29(1): 75-81, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9862853

ABSTRACT

Recently, we described a new strategy for hepatocyte transplantation, using retrorsine/partial hepatectomy (PH) in a DPPIV- mutant Fischer rat model. Treatment of rats with retrorsine, a pyrrolizidine alkaloid, blocks endogenous hepatocytes from proliferating, so that after exposure to this agent coupled with PH and hepatocyte transplantation, transplanted hepatocytes selectively repopulate the liver. In the present study, we determined whether this method of cell transplantation can restore biosynthetic and physiological function in the liver by transplanting normal hepatocytes into rats genetically deficient in albumin synthesis, the Nagase analbuminic rat (NAR). After hepatocyte transplantation, albumin mRNA and protein were identified in the liver by in situ hybridization and immunohistochemistry, respectively, and serum albumin levels were determined using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), Western blot, and enzyme-linked immunosorbent assay (ELISA) methods. At 1 month posttransplantation, large clusters of cells expressing albumin mRNA and protein were identified in the liver, representing approximately 50% of hepatocytes for albumin mRNA and approximately 61% for protein. At 2 months' posttransplantation, cells expressing albumin mRNA represented approximately 77% of hepatocyte mass, and cells expressing albumin protein represented approximately 81% of total hepatocyte mass. Hepatocyte-transplanted NAR also exhibited normal or near-normal serum albumin levels (3.0 +/- 0.2 g/dL). High levels of serum albumin were sustained for the 2-month duration of experiments. These results demonstrate the ability of this protocol for hepatocyte transplantation to restore a major biosynthetic and physiological function of the liver, and suggest its potential use as a method to treat genetic-based or acquired liver diseases.


Subject(s)
Acetylglucosaminidase/deficiency , Cell Transplantation , Liver/metabolism , Serum Albumin/metabolism , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Cell Separation , Diet , In Situ Hybridization , Liver/pathology , Male , Pyrrolizidine Alkaloids/pharmacology , RNA, Messenger/biosynthesis , Rats , Rats, Inbred F344 , Rats, Sprague-Dawley , Serum Albumin/biosynthesis , Serum Albumin/deficiency
18.
Cancer Res ; 58(24): 5825-34, 1998 Dec 15.
Article in English | MEDLINE | ID: mdl-9865742

ABSTRACT

Recently, we described a new model for hepatocyte transplantation with nearly total replacement of the liver by exogenous hepatocytes (E. Laconi et al., Am. J. Pathol., 153: 319-329, 1998). The model is based on the mitoinhibitory effect of the pyrrolizidine alkaloid retrorsine on hepatocytes in the resident liver while transplanted hepatocytes proliferate. In this study, we exploit this novel approach to address the important and controversial issue of whether hepatocytes, when proliferating extensively, undergo dedifferentiation and give rise to foci of undifferentiated hepatocytes. Genetically marked hepatocytes (isolated from normal Dipeptidyl peptidase IV+ Fischer 344 rats) were delivered intraportally (2 x 10(6) cells) into the liver of retrorsine-treated Dipeptidyl peptidase IV- mutant Fischer 344 rats in conjunction with partial hepatectomy. Transplanted hepatocytes were detected histochemically or immunohistochemically, and cell proliferation was studied by in situ hybridization for histone-3 mRNA. Expression of alpha-fetoprotein (AFP) mRNA, a marker of hepatocyte dedifferentiation, was also revealed by in situ hybridization. One day after partial hepatectomy and hepatocyte transplantation, endogenous hepatocytes and oval cells expanding in the liver expressed histone-3 mRNA (cells had entered S phase); 2 days later, transplanted hepatocytes and nonparenchymal cells also expressed histone-3 mRNA. Although the majority of endogenous hepatocytes did not divide and became arrested as quiescent megalocytes, the exogenous hepatocytes, as well as newly formed small hepatocytes, most probably derived from liver progenitor cells, underwent extensive proliferation. After 7-14 days, the nonparenchymal cells stopped proliferating, but transplanted hepatocytes and small endogenous hepatocytes continued to proliferate for 1 month, forming foci of dividing parenchymal cells. Although many of the hepatocytes in clusters were in S phase (histone-3 mRNA positive), none expressed AFP mRNA. In contrast, high expression of AFP mRNA was observed in proliferating oval and transitional cells, forming duct-like structures of cytokeratin-19-positive cells. From these studies, we conclude that hepatocyte proliferation in the adult liver is not associated with dedifferentiation.


Subject(s)
Cell Transplantation , Liver Regeneration , Liver Transplantation , Pyrrolizidine Alkaloids/pharmacology , alpha-Fetoproteins/metabolism , Animals , Cell Differentiation , Cell Division , Dipeptidyl Peptidase 4/genetics , Hepatectomy , Histones/metabolism , Intermediate Filaments/metabolism , Mutation , RNA, Messenger/metabolism , Rats , Rats, Inbred F344 , alpha-Fetoproteins/analysis
19.
Am J Pathol ; 153(1): 319-29, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9665494

ABSTRACT

Genetically marked hepatocytes from dipeptidyl peptidase (DPP) IV+ Fischer 344 rats were transplanted into the liver of DPPIV- mutant Fischer 344 rats after a combined treatment with retrorsine, a pyrrolizidine alkaloid that blocks the hepatocyte cell cycle, and two-thirds partial hepatectomy. In female rats, clusters of proliferated DPPIV+ hepatocytes containing 20 to 50 cells/cluster, mostly derived from single transplanted cells, were evident at 2 weeks, increasing in size to hundreds of cells per cluster at 1 month and 1000 to several thousand cells per cluster at 2 months, representing 40 to 60% of total hepatocyte mass. This level of hepatocyte replacement remained constant for up to 1 year, the duration of experiments conducted. In male rats, liver replacement occurred more rapidly and was more extensive, with transplanted hepatocytes representing 10 to 15% of hepatocyte mass at 2 weeks, 40 to 50% at 1 month, 90 to 95% at 2 months, 98% at 4 months, and 99% at 9 months. Transplanted hepatocytes were integrated into the parenchymal plates, exhibited unique hepatic biochemical functions, and fully reconstituted a normal hepatic lobular structure. The extensive proliferation of transplanted cells in this setting of persistent inhibition of resident hepatocytes represents a new general model to study basic aspects of liver repopulation with potential applications in chronic liver disease and ex vivo gene therapy.


Subject(s)
Cell Transplantation/methods , Liver Transplantation/methods , Liver/cytology , Pyrrolizidine Alkaloids/pharmacology , Adenosine Triphosphatases/metabolism , Animals , Cell Division , Dipeptidyl Peptidase 4/metabolism , Female , Glucose-6-Phosphate/metabolism , Glycogen/metabolism , Hepatectomy , Keratins/metabolism , Liver/metabolism , Male , Rats , Rats, Inbred F344 , Rats, Mutant Strains , Serum Albumin/metabolism , Sex Factors , Time Factors
20.
Eur J Biochem ; 251(3): 597-604, 1998 Feb 01.
Article in English | MEDLINE | ID: mdl-9490031

ABSTRACT

Administration of either ammonia or glycine to both rats and mice results in an increased synthesis in the liver and urinary excretion of orotic acid. The two most relevant observations obtained are that carbamoyl phosphate synthesized inside the mitochondria is involved in the increased synthesis of orotic acid and that this latter process is almost completely abolished by cycloheximide and actinomycin D, inhibitors of protein and RNA synthesis. Orotic acid synthesis could be controlled by an induction-suppression mechanism. Inhibition of synthesis of excess orotic acid brought about by N-(phosphonacetyl)-L-aspartic acid but not by acivicin, suggests that glutamine-dependent cytosolic synthesis of carbamoyl phosphate, is not involved. Administration of ornithine together with glycine completely suppressed the synthesis of orotic acid, but promoted a twofold increase of urea excretion. The concentration of ornithine rather than that of carbamoyl phosphate or the activity of the enzymes involved, may represent a limiting factor controlling both the flux of ammonia in the urea cycle and the availability of mitochondrial carbamoyl phosphate for orotic acid synthesis. Two enzymes have been found to be induced by glycine: ornithine decarboxylase and aspartate transcarbamoylase (aspartate carbamoyltransferase). Both enzymes may contribute to the increase in orotic acid synthesis, aspartate transcarbamoylase more directly and ornithine decarboxylase by lowering the ornithine concentration. Ornithine decarboxylase activity was completely suppressed but that of aspartate transcarbamoylase was further increased by cycloheximide treatment. Inhibition of orotic acid biosynthesis by cycloheximide appears to be the result of a decreased availability in the cytosol of carbamoyl phosphate synthesized inside the mitochondria.


Subject(s)
Ammonium Chloride/pharmacology , Cycloheximide/pharmacology , Glycine/pharmacology , Liver/metabolism , Mitochondria, Liver/metabolism , Ornithine Decarboxylase/biosynthesis , Orotic Acid/metabolism , Animals , Carbamyl Phosphate/metabolism , Dactinomycin/pharmacology , Enzyme Induction , Enzyme Inhibitors/pharmacology , Isoxazoles/pharmacology , Kinetics , Liver/drug effects , Male , Mice , Mice, Inbred C57BL , Mitochondria, Liver/drug effects , Models, Biological , Rats , Rats, Inbred F344
SELECTION OF CITATIONS
SEARCH DETAIL
...